According to a statement from ODS director, Stefan M. Pasiakos, PhD, the strategic plan outlines three primary goals: advance research, expand capacity, and foster stewardship.
The National Health Institute’s Office of Dietary Supplements has released its Strategic Plan for 2025-2029. According to a statement from ODS director, Stefan M. Pasiakos, PhD, the strategic plan outlines three primary goals: advance research, expand capacity, and foster stewardship.
“These goals and their interconnected objectives will enable ODS to develop new research opportunities and promote resources that build our understanding of how dietary supplements modulate resilience and health across the lifespan in diverse populations. This new strategic plan provides the foundation for the coordination of dietary supplement science and its translation to inform the public’s choices for the safe and effective use of dietary supplements,” said Pasiakos in the statement.
Each goal outlined it the plan has multiple objectives. In its goal to advance dietary supplement research, ODS has three objectives:
In expanding its research capacity, ODS has two objectives:
Finally, when it comes to its stewardship goals, ODS has four objectives:
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.